KNOW
 YOUR MIND

Enabling precision medicine 
for 
neurodegenerative
diseases 

lines1
lines2
lines3
lines1
lines3
lines2

Our vision is to be the premier provider of information and technology to researchers and clinicians in order to improve brain health.

 Our mission

To provide broad access to biomarkers of neurological pathologies, essential enabling tools to accelerate the development and approval of effective blood tests and therapies to diagnose and treat Lewy body dementia, Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.

NeuroDex is developing a suite of blood-based biomarkers that can identify patients with synucleinopathies even in the context of different forms of dementia.
This technology relies on NeuroDex’s recent advances in isolating cell-specific extracellular vesicles (exosomes) from plasma and detecting protein markers of disease in the contents or on the surface of NDEs.

Our Partners

Yale University
ADDF